ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 805,08
0,44%
Dow Jones
44 025,81
1,24%
DAX
21 244,51
0,96%
Brent Oil
78,575
-0,22%
Bitcoin
105 238,89
-0,88%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ProMIS Neurosciences Inc (PMN) Cours

ProMIS Neurosciences Inc

ProMIS Neurosciences Inc (PMN)

ProMIS Neurosciences Inc
0,988999
0,00
(0,00%)
Fermé 22 Janvier 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,988999
Prix Achat
0,9403
Prix Vente
0,98
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,87 Plage de 52 semaines 2,61
Cap du marché
29,557M
Clôture Veille
0,988999
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
75 208
Actions en circulation
29 885 452
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-13,57
Bénéfice par action (BPA)
-0,44
Chiffre d'affairess
-
Bénéfice net
-13,21M

À propos de ProMIS Neurosciences Inc

ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investi... ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.promisneurosciences.com
Siège social
Toronto, Ontario, Can
Fondé
-
ProMIS Neurosciences Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PMN. Le dernier cours de clôture d'ProMIS Neurosciences était de US$0,99. Au cours de la dernière année, les actions de ProMIS Neurosciences ont été négociées dans une fourchette de prix de US$ 0,87 à US$ 2,61.

ProMIS Neurosciences compte actuellement 29 885 452 actions en circulation. La capitalisation boursière d'ProMIS Neurosciences est de US$29,56 million. ProMIS Neurosciences a un ratio cours/bénéfice (ratio PE) de -13.57.

PMN Dernières nouvelles

Plus de nouvelles

ProMIS Neurosciences Issues Letter to Shareholders

CAMBRIDGE, Massachusetts, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN) (ProMIS), a clinical-stage biotechnology company focused on the generation and development of...

13 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

10 Janvier 2025
Edgar (US Regulatory)

ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease

CAMBRIDGE, Massachusetts, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for...

10 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

08 Janvier 2025
Edgar (US Regulatory)

ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Nov. 26, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and...

26 Novembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

21 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 Novembre 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

14 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.0754998.264805692390.91351.020.879413730.9202154CS
40.0589996.343978494620.931.130.879526630.98332256CS
12-0.071001-6.698207547171.061.570.87752081.03873856CS
26-0.981001-49.79700507611.972.20.871163481.35727768CS
52-1.221001-55.24891402712.212.610.87654481.42873475CS
156-5.951001-85.74929394816.949.80.87677933.32310166CS
260-5.951001-85.74929394816.949.80.87677933.32310166CS

PMN - Frequently Asked Questions (FAQ)

What is the current ProMIS Neurosciences share price?
The current share price of ProMIS Neurosciences is US$ 0,988999
How many ProMIS Neurosciences shares are in issue?
ProMIS Neurosciences has 29 885 452 shares in issue
What is the market cap of ProMIS Neurosciences?
The market capitalisation of ProMIS Neurosciences is USD 29,56M
What is the 1 year trading range for ProMIS Neurosciences share price?
ProMIS Neurosciences has traded in the range of US$ 0,87 to US$ 2,61 during the past year
What is the PE ratio of ProMIS Neurosciences?
The price to earnings ratio of ProMIS Neurosciences is -13,57
What is the reporting currency for ProMIS Neurosciences?
ProMIS Neurosciences reports financial results in USD
What is the latest annual profit for ProMIS Neurosciences?
The latest annual profit of ProMIS Neurosciences is USD -13,21M
What is the registered address of ProMIS Neurosciences?
The registered address for ProMIS Neurosciences is SUITE 200, 1920 YONGE STREET, TORONTO, ONTARIO, M4S 3E2
What is the ProMIS Neurosciences website address?
The website address for ProMIS Neurosciences is www.promisneurosciences.com
Which industry sector does ProMIS Neurosciences operate in?
ProMIS Neurosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AALAmerican Airlines Group Inc
US$ 18,64
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,3208
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,02
(0,00%)
0
AACGATA Creativity Global
US$ 0,94
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 18,64
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,3208
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,02
(0,00%)
0
AACGATA Creativity Global
US$ 0,94
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 18,64
(0,00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74,3208
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,02
(0,00%)
0
AACGATA Creativity Global
US$ 0,94
(0,00%)
0

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
PMN
ProMIS Neurosciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés